<!DOCTYPE html>
<html>
	<head>
		<meta charset="utf-8">
		

<meta name="viewport" content="width=device-width, initial-scale=1">

<title>[新聞] 中研院找出蛋白質「品管機制」 阿茲海默 - 看板 Gossiping - 批踢踢實業坊</title>
<meta name="robots" content="all">
<meta name="keywords" content="Ptt BBS 批踢踢">
<meta name="description" content="1.媒體來源:
自由時報
2.完整新聞標題:
中研院找出蛋白質「品管機制」 阿茲海默症治療露曙光
3.完整新聞內文:
">
<meta property="og:site_name" content="Ptt 批踢踢實業坊">
<meta property="og:title" content="[新聞] 中研院找出蛋白質「品管機制」 阿茲海默">
<meta property="og:description" content="1.媒體來源:
自由時報
2.完整新聞標題:
中研院找出蛋白質「品管機制」 阿茲海默症治療露曙光
3.完整新聞內文:
">
<link rel="canonical" href="https://www.ptt.cc/bbs/Gossiping/M.1528693022.A.1D6.html">

<link rel="stylesheet" type="text/css" href="bbs-common.css">
<link rel="stylesheet" type="text/css" href="bbs-base.css" media="screen">
<link rel="stylesheet" type="text/css" href="bbs-custom.css">
<link rel="stylesheet" type="text/css" href="pushstream.css" media="screen">
<link rel="stylesheet" type="text/css" href="bbs-print.css" media="print">




	</head>
    <body>
		
<div id="fb-root"></div>
<script>(function(d, s, id) {
var js, fjs = d.getElementsByTagName(s)[0];
if (d.getElementById(id)) return;
js = d.createElement(s); js.id = id;
js.src = "//connect.facebook.net/en_US/all.js#xfbml=1";
fjs.parentNode.insertBefore(js, fjs);
}(document, 'script', 'facebook-jssdk'));</script>

<div id="topbar-container">
	<div id="topbar" class="bbs-content">
		<a id="logo" hrefhref="http://www.ptt.cc/bbs/">批踢踢實業坊</a>
		<span>&rsaquo;</span>
		<a class="board" hrefhref="http://www.ptt.cc/bbs/Gossiping/index.html"><span class="board-label">看板 </span>Gossiping</a>
		<a class="right small" hrefhref="http://www.ptt.cc/about.html">關於我們</a>
		<a class="right small" hrefhref="http://www.ptt.cc/contact.html">聯絡資訊</a>
	</div>
</div>
<div id="navigation-container">
	<div id="navigation" class="bbs-content">
		<a class="board" hrefhref="http://www.ptt.cc/bbs/Gossiping/index.html">返回看板</a>
		<div class="bar"></div>
		<div class="share">
			<span>分享</span>
			<div class="fb-like" data-send="false" data-layout="button_count" data-width="90" data-show-faces="false" data-href="http://www.ptt.cc/bbs/Gossiping/M.1528693022.A.1D6.html"></div>

			<div class="g-plusone" data-size="medium"></div>
<script type="text/javascript">
window.___gcfg = {lang: 'zh-TW'};
(function() {
var po = document.createElement('script'); po.type = 'text/javascript'; po.async = true;
po.src = 'https://apis.google.com/js/plusone.js';
var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(po, s);
})();
</script>

		</div>
	</div>
</div>
<div id="main-container">
    <div id="main-content" class="bbs-screen bbs-content"><div class="article-metaline"><span class="article-meta-tag">作者</span><span class="article-meta-value">pitalvlu (pital)</span></div><div class="article-metaline-right"><span class="article-meta-tag">看板</span><span class="article-meta-value">Gossiping</span></div><div class="article-metaline"><span class="article-meta-tag">標題</span><span class="article-meta-value">[新聞] 中研院找出蛋白質「品管機制」 阿茲海默</span></div><div class="article-metaline"><span class="article-meta-tag">時間</span><span class="article-meta-value">Mon Jun 11 12:56:59 2018</span></div>
1.媒體來源:

自由時報


2.完整新聞標題:

中研院找出蛋白質「品管機制」 阿茲海默症治療露曙光


3.完整新聞內文:

<a href="https://i.imgur.com/bufMcr9.jpg" target="_blank" rel="nofollow">https://i.imgur.com/bufMcr9.jpg</a>
<div class="richcontent"><blockquote class="imgur-embed-pub" lang="en" data-id="bufMcr9"><a href="//imgur.com/bufMcr9"></a></blockquote><script async src="http://s.imgur.com/min/embed.js" charset="utf-8"></script></div>缺陷蛋白質會被CRL2辨識並降解。CRL2有不同的受器，可一對一找出缺陷蛋白質尾端的特
定短胜肽。（圖由中研院提供）

〔記者吳欣恬／台北報導〕包括阿茲海默症、帕金森氏症、漸凍人以及癌症等疾病都和人
體內缺陷蛋白質堆積有關，中研院分子生物所副研究員顏雪琪研究團隊耗時3年找出能將
缺陷蛋白質辨識和清除的「品管機制」，未來有助於找出疾病的治療方式、延緩老化，甚
至應用於蛋白質生物工程。此研究上個月發表於國際期刊「分子細胞（Molecular Cell）
」上，並獲選為當期重點論文。

顏雪琪指出，人體45%是蛋白質，包括胞器構造、基因調節、代謝催化、物質傳輸、訊息
傳遞以及免疫反正等許多生理功能都是由蛋白質運作。但蛋白質可能因製程瑕疵或環境刺
激發生斷裂、錯誤摺疊以及聚集沉澱等缺陷，如果人體不能將缺陷蛋白質辨識並清除，而
讓缺陷蛋白質持續堆積在體內，就可能導致疾病。

顏雪琪於2008年建立「全蛋白質穩定度監測系統」（Global Protein Stability, GPS）
，可同時偵測細胞中上萬個蛋白質的穩定度。透過此項技術，2015年研究團隊就先在硒蛋
白的研究中發現，蛋白質CRL2具有蛋白質品管的功能，本次研究則更進一步掌握CRL2的品
管機制。

顏雪琪說，CRL2能透過缺陷蛋白質的尾端特徵加以辨識，並將其降解成無害的胜肽或胺基
酸。她指出，CRL2有不同的受器，可一對一找出缺陷蛋白質尾端的特定短胜肽，進而標記
並清除。這些缺陷蛋白質尾端的特定短胜肽由6至10個胺基酸組成，不同序列的短胜肽也
引導不同的降解速度，可提高調控蛋白質降解速率的準確度，未來可望應用於蛋白質生物
工程。

另外，除了針對缺陷蛋白質，研究團隊也發現CRL2遇到正常但帶有和缺陷蛋白質同樣的尾
端特徵的蛋白質也會將其辨識、降解。研究團隊已著手檢驗此機制的其他生理功能及對蛋
白質的整體影響。

<a href="https://i.imgur.com/4OoliIY.jpg" target="_blank" rel="nofollow">https://i.imgur.com/4OoliIY.jpg</a>
<div class="richcontent"><blockquote class="imgur-embed-pub" lang="en" data-id="4OoliIY"><a href="//imgur.com/4OoliIY"></a></blockquote><script async src="http://s.imgur.com/min/embed.js" charset="utf-8"></script></div>中研院分子生物所副研究員顏雪琪（右2）研究團隊找出能將缺陷蛋白質辨識和清除的「
品管機制」，論文第一作者為台大生科院博士生林秀娟（左2）。（記者吳欣恬攝）


4.完整新聞連結 (或短網址):

<a href="https://reurl.cc/k4LL" target="_blank" rel="nofollow">https://reurl.cc/k4LL</a>


5.備註:

--
<span class="f2">※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 180.204.81.102
</span><span class="f2">※ 文章網址: <a href="https://www.ptt.cc/bbs/Gossiping/M.1528693022.A.1D6.html" target="_blank" rel="nofollow">https://www.ptt.cc/bbs/Gossiping/M.1528693022.A.1D6.html</a>
</span><div class="push"><span class="f1 hl push-tag">→ </span><span class="f3 hl push-userid">milk250</span><span class="f3 push-content">: 從鯊魚大腦來的嗎</span><span class="push-ipdatetime"> 06/11 12:58
</span></div><div class="push"><span class="hl push-tag">推 </span><span class="f3 hl push-userid">heybro</span><span class="f3 push-content">: 大家坐穩 生科要起飛了</span><span class="push-ipdatetime"> 06/11 12:59
</span></div><div class="push"><span class="hl push-tag">推 </span><span class="f3 hl push-userid">xzcb2008</span><span class="f3 push-content">: 都很普</span><span class="push-ipdatetime"> 06/11 12:59
</span></div><div class="push"><span class="hl push-tag">推 </span><span class="f3 hl push-userid">end56</span><span class="f3 push-content">: 資進黨 趕快all in 生技</span><span class="push-ipdatetime"> 06/11 13:00
</span></div><div class="push"><span class="f1 hl push-tag">→ </span><span class="f3 hl push-userid">sawadiga</span><span class="f3 push-content">: 早就給拒絕了</span><span class="push-ipdatetime"> 06/11 13:01
</span></div><div class="push"><span class="hl push-tag">推 </span><span class="f3 hl push-userid">ECZEMA</span><span class="f3 push-content">: 恩 美麥</span><span class="push-ipdatetime"> 06/11 13:01
</span></div><div class="push"><span class="hl push-tag">推 </span><span class="f3 hl push-userid">TaiwanUp</span><span class="f3 push-content">: 推</span><span class="push-ipdatetime"> 06/11 13:01
</span></div><div class="push"><span class="hl push-tag">推 </span><span class="f3 hl push-userid">MADAOTW</span><span class="f3 push-content">: 難喔！應用到臨床至少十年起跳，而且失敗率極高</span><span class="push-ipdatetime"> 06/11 13:02
</span></div><div class="push"><span class="f1 hl push-tag">→ </span><span class="f3 hl push-userid">twpost</span><span class="f3 push-content">: 再20年吧</span><span class="push-ipdatetime"> 06/11 13:03
</span></div><div class="push"><span class="f1 hl push-tag">→ </span><span class="f3 hl push-userid">soarling</span><span class="f3 push-content">: 37</span><span class="push-ipdatetime"> 06/11 13:06
</span></div><div class="push"><span class="hl push-tag">推 </span><span class="f3 hl push-userid">turbomons</span><span class="f3 push-content">: 這算是某種蛋白酶吧</span><span class="push-ipdatetime"> 06/11 13:09
</span></div><div class="push"><span class="hl push-tag">推 </span><span class="f3 hl push-userid">lemon81824</span><span class="f3 push-content">: 每次這種訊息出現，就有一堆人只會酸，有種別依賴這些</span><span class="push-ipdatetime"> 06/11 13:12
</span></div><div class="push"><span class="f1 hl push-tag">→ </span><span class="f3 hl push-userid">lemon81824</span><span class="f3 push-content">: 被唱衰的科學發現喔…</span><span class="push-ipdatetime"> 06/11 13:12
</span></div><div class="push"><span class="hl push-tag">推 </span><span class="f3 hl push-userid">woulin</span><span class="f3 push-content">: KMT表示：</span><span class="push-ipdatetime"> 06/11 13:13
</span></div><div class="push"><span class="hl push-tag">推 </span><span class="f3 hl push-userid">michaelwu</span><span class="f3 push-content">: 加油</span><span class="push-ipdatetime"> 06/11 13:14
</span></div><div class="push"><span class="f1 hl push-tag">→ </span><span class="f3 hl push-userid">JOKO58802218</span><span class="f3 push-content">: 快投入市場應用啦！</span><span class="push-ipdatetime"> 06/11 13:16
</span></div><div class="push"><span class="hl push-tag">推 </span><span class="f3 hl push-userid">puretruthson</span><span class="f3 push-content">: 台灣科學家太棒了</span><span class="push-ipdatetime"> 06/11 13:16
</span></div><div class="push"><span class="hl push-tag">推 </span><span class="f3 hl push-userid">anus1130</span><span class="f3 push-content">: 這我十年前看過 從鯊魚來的</span><span class="push-ipdatetime"> 06/11 13:38
</span></div><div class="push"><span class="f1 hl push-tag">→ </span><span class="f3 hl push-userid">mimikillua</span><span class="f3 push-content">: 每個發現最後都加一句露曙光 可就沒人完成過</span><span class="push-ipdatetime"> 06/11 13:51
</span></div><div class="push"><span class="hl push-tag">推 </span><span class="f3 hl push-userid">ace4</span><span class="f3 push-content">: 這種簽自願人體實驗應該很多人報名 可惜會有一堆腦殘團體反</span><span class="push-ipdatetime"> 06/11 14:48
</span></div><div class="push"><span class="f1 hl push-tag">→ </span><span class="f3 hl push-userid">ace4</span><span class="f3 push-content">: 對</span><span class="push-ipdatetime"> 06/11 14:48
</span></div><div class="push"><span class="hl push-tag">推 </span><span class="f3 hl push-userid">hellam</span><span class="f3 push-content">: 推</span><span class="push-ipdatetime"> 06/11 15:18
</span></div><div class="push"><span class="hl push-tag">推 </span><span class="f3 hl push-userid">or0706555</span><span class="f3 push-content">: 推</span><span class="push-ipdatetime"> 06/11 15:20
</span></div><div class="push"><span class="f1 hl push-tag">→ </span><span class="f3 hl push-userid">IHD</span><span class="f3 push-content">: 倫理不會過啦 以為自助餐喔 你說得就算? 現在不是古代啦</span><span class="push-ipdatetime"> 06/11 16:54
</span></div></div>
    
    <div id="article-polling" data-pollurlhref="http://www.ptt.cc/poll/Gossiping/M.1528693022.A.1D6.html?cacheKey=2100-24619301&amp;offset=4567&amp;offset-sig=fb95815ccfbc4106873206f9ec4b3906f37a4146" data-longpollurl="/v1/longpoll?id=b26fbfd5fb8dfdf13e053d18ce106081f04edd89" data-offset="4567"></div>
    

    
<div class="bbs-screen bbs-footer-message">本網站已依台灣網站內容分級規定處理。此區域為限制級，未滿十八歲者不得瀏覽。</div>

</div>

		

<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-32365737-1', {
    cookieDomain: 'ptt.cc',
    legacyCookieDomain: 'ptt.cc'
  });
  ga('send', 'pageview');
</script>


		
<script src="jquery.min.js"></script>
<script src="script>

    </body>
</html>
